Cellosaurus

PubMed=10074925; DOI=10.1002/(SICI)1097-0215(19990315)80:6<903::AID-IJC17>3.0.CO;2-8
Bruch J., Wohr G., Bruderlein S., Barbi G., Wolter H., Dixkens C., Mattfeldt T., Moller P., Paiss T., Hautmann R., Vogel W., Hameister H.
Detailed marker chromosome analysis in cell line U-BLC1, established from transitional-cell carcinoma of the bladder.
Int. J. Cancer 80:903-910(1999)

PubMed=24367658; DOI=10.1371/journal.pone.0084411
Ross R.L., Burns J.E., Taylor C.F., Mellor P., Anderson D.H., Knowles M.A.
Identification of mutations in distinct regions of p85 alpha in urothelial cancer.
PLoS ONE 8:E84411-E84411(2013)

PubMed=24035680; DOI=10.1016/j.eururo.2013.08.057
Hurst C.D., Platt F.M., Knowles M.A.
Comprehensive mutation analysis of the TERT promoter in bladder cancer and detection of mutations in voided urine.
Eur. Urol. 65:367-369(2014)

PubMed=29732388; DOI=10.3233/BLC-180167
Zuiverloon T.C.M., de Jong F.C., Costello J.C., Theodorescu D.
Systematic review: characteristics and preclinical uses of bladder cancer cell lines.
Bladder Cancer 4:169-183(2018)